KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) EBT Margin (2016 - 2026)

Fulgent Genetics' EBT Margin history spans 12 years, with the latest figure at 36.52% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 2056.0% to 36.52% in Q1 2026 year-over-year; TTM through Mar 2026 was 9.49%, a 569.0% increase, with the full-year FY2025 number at 2.56%, up 1395.0% from a year prior.
  • EBT Margin hit 36.52% in Q1 2026 for Fulgent Genetics, down from 8121.25% in the prior quarter.
  • Over the last five years, EBT Margin for FLGT hit a ceiling of 8121.25% in Q4 2025 and a floor of 36.52% in Q1 2026.
  • Historically, EBT Margin has averaged 499.98% across 5 years, with a median of 12.36% in 2024.
  • Biggest five-year swings in EBT Margin: plummeted -9488bps in 2023 and later surged 812506bps in 2025.
  • Tracing FLGT's EBT Margin over 5 years: stood at 1.66% in 2022, then soared by 93bps to 3.22% in 2023, then crashed by -218bps to 3.81% in 2024, then skyrocketed by 213385bps to 8121.25% in 2025, then tumbled by -100bps to 36.52% in 2026.
  • Business Quant data shows EBT Margin for FLGT at 36.52% in Q1 2026, 8121.25% in Q4 2025, and 8.93% in Q3 2025.